N3F-35875-83009
3 vaccinations
1 coded response
13 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 320 / FL
- Registered
- 2021-10-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-13
Dose 1 — Pfizer-BioNTech
-
2021-04-03
Dose 2 — Pfizer-BioNTech
-
2021-10-08
Registered in v-safe
-
2021-10-08
Dose 3 — Pfizer-BioNTech
- 2021-10-08
-
2021-10-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-10
- 2021-10-11
- 2021-10-12
- 2021-10-13
- 2021-10-14
- 2021-10-15
- 2021-10-22
- 2021-10-31
- 2021-11-07
- 2021-11-12
-
2022-01-07
Survey response — 3 months, dose 3MedDRA: Headache, Nasal congestion, Oropharyngeal pain, Respiratory tract congestion — Feeling: GoodFree text: Stuffy nose, sore throat, headache, congestionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-13 | Pfizer-BioNTech | No |
| 2 | 2021-04-03 | Pfizer-BioNTech | No |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 3
Symptoms: Stuffy nose, sore throat, headache, congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release